Human Kallikrein 15 Antibody, R&D Systems™

Kallikrein 15

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

KLK15

Mouse myeloma cell line NS0-derived recombinant human Kallikrein 15 isoform 1 Leu23-Asn256 (predicted)

500 μg

Primary

Detects human Kallikrein 15 in Western blots. In Western blots, approximately 25% cross-reactivity with recombinant human (rh) Factor X is observed and no cross-reactivity with recombinant mouse HGFA, rhKallikrein 3, 5, 6, 8, 10, 11, rhThrombin, or rhuPA is observed.

Human

Purified

Western Blot, Immunoprecipitation

252819

Western Blot 1 ug/mL, Immunoprecipitation 25 ug/mL

ACO, ACO protease, EC 3.4.21, EC 3.4.21.-, EC 3.4.21.4, HSRNASPH, kallikrein 15, kallikrein-15, kallikrein-like serine protease, kallikrein-related peptidase 15, KLK15, Prostinogen

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

55554

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2a